Polymorphisms associated with circulating sex hormone levels in postmenopausal women.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of the National Cancer Institute

• Publication date

  2005-01-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/JNCI/DJH167PMID 15199113
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aromatase: Biologic Relevance of Tissue-Specific Expression

  2004cited by this paper
• Human controlled ovarian hyperstimulation outcome is a polygenic trait.

  2004cited by this paper
• Mathematical multi-locus approaches to localizing complex human trait genes

  2003cited by this paper
• A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.

  2003cited by this paper
• Sources of estrogen and their importance.

  2003cited by this paper
• No association between a single nucleotide polymorphism in CYP19 and breast cancer risk.

  2002cited by this paper
• Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies.

  2002cited by this paper
• Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial.

  2002cited by this paper
• Endometrial volume and thickness measurements predict pituitary suppression and non-suppression during IVF.

  2002cited by this paper
• Tissue-specific synthesis and oxidative metabolism of estrogens.

  2000cited by this paper
• Ethnic-related differences in the frequency distribution of genetic polymorphisms in the CYP1A1 and CYP1B1 genes in Japanese and Caucasian populations

  2000cited by this paper
• Genetic variants of CYP19 (aromatase) and breast cancer risk

  2000cited by this paper
• Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases

  2000cited by this paper
• Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk.

  2000cited by this paper
• Characterization of single-nucleotide polymorphisms in coding regions of human genes

  1999cited by this paper
• EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer.

  1999cited by this paper
• Characterization of single-nucleotide polymorphisms in coding regions of human genes

  1999cited by this paper
• Aromatase and breast cancer susceptibility.

  1999cited by this paper
• The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer.

  1999cited by this paper
• Human variant sex hormone-binding globulin (SHBG) with an additional carbohydrate chain has a reduced clearance rate in rabbit.

  1998cited by this paper
• A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey.

  1997cited by this paper
• Human familial and sporadic breast cancer: analysis of the coding regions of the 17β-hydroxysteroid dehydrogenase 2 gene (EDH17B2) using a single-strand conformation polymorphism assay

  1994cited by this paper
• Handbook of Human Genetic Linkage

  1994cited by this paper
• Simplification of IVF: minimal monitoring and the use of subcutaneous highly purified FSH administration for ovulation induction.

  1994cited by this paper
• The international variation in breast cancer rates: An epidemiological assessment

  1991cited by this paper
• Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route.

  1987cited by this paper
• Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism.

  1987cited by this paper
• Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism.

  1987cited by this paper
• Significance of aromatase activity in human breast cancer.

  1982cited by this paper
• Hormones and breast cancer.

  1966cited by this paper

• Significance of Follicle-Stimulating Hormone Receptor Gene Single-Nucleotide Polymorphism rs6165/rs6166 Analysis for Infertility-Associated Ovarian Disease Susceptibility Prediction and Optimized Individualized Ovulation Induction/Ovarian Stimulation

  2026cites this paper
• Combined effects and potential mechanisms of phthalate metabolites on serum sex hormones among reproductive-aged women: An integrated epidemiology and computational toxicology study.

  2024cites this paper
• Genetic Background of Medication-Related Osteonecrosis of the Jaw: Current Evidence and Future Perspectives

  2024cites this paper
• Association between the aromatase (CYP19A1) gene variant rs10046 and cardiovascular risk in postmenopausal women

  2024cites this paper
• Sex-Hormone-Binding Globulin Gene Polymorphisms and Breast Cancer Risk in Caucasian Women of Russia

  2024cites this paper
• The physiological effect of breast cancer on activity of aromatase enzyme and some concentrations of hormones and biochemical in the women in Baghdad city

  2023cites this paper
• SNP of Aromatase Predict Long-term Survival and Aromatase Inhibitor Toxicity in Patients with Early Breast Cancer: A Biomarker Analysis of the GIM4 and GIM5 Trials

  2023cites this paper
• Features of gene polymorphism associations linked with sex hormone binding globulin level and breast cancer of various molecular biological subtypes

  2023cites this paper
• A composite menstrual cycle of captive orangutans, with associated hormonal and behavioral variability

  2022cites this paper
• Endogenous sex hormones, aromatase activity and lung cancer risk in postmenopausal never‐smoking women

  2022cites this paper
• Genetic Variation and Mendelian Randomization Approaches.

  2022cites this paper
• Multivariate, region‐based genetic analyses of facets of reproductive aging in White and Black women

  2022cites this paper
• Association of CYP19 Gene Polymorphism with Breast Cancer in Iraqi Women

  2022cites this paper
• Association of polymorphisms in the sex hormone genes with the presence and severity of coronary artery disease.

  2022cites this paper
• Immuno-regenerative biomaterials for in situ cardiovascular tissue engineering - Do patient characteristics warrant precision engineering?

  2021cites this paper
• Genetic variants predictive of reproductive aging are associated with vasomotor symptoms in a multiracial/ethnic cohort

  2021cites this paper
• The association between CYP17A1, CYP19A1, and HSD17B1 gene polymorphisms of estrogen synthesis pathway and ovarian cancer predisposition

  2021cites this paper
• Associations among maternal perfluoroalkyl substance levels, fetal sex-hormone enzymatic gene polymorphisms, and fetal sex hormone levels in the Hokkaido study.

  2021cites this paper
• The effect of sex hormone-binding globulin gene polymorphisms on the serum level of SHBG hormone in the men with prostate cancer

  2021cites this paper
• Associations of genetic susceptibility to 16 cancers with risk of breast cancer overall and by intrinsic subtypes

  2021cites this paper
• Evaluation of reproductive hormones in Egyptian workers occupationally exposed to di-2-ethylhexyl phthalate (DEHP): a cross-sectional study

  2021cites this paper
• Immuno-regenerative biomaterials for in situ cardiovascular tissue engineering – Do patient characteristics warrant precision engineering?

  2021cites this paper
• Association between single nucleotide polymorphism of the CYP19A1 and ESR2 genes and endometriosis

  2021cites this paper
• Association of genetic polymorphisms with local steroid metabolism in human benign breasts.

  2021cites this paper
• Genetic variations in estrogen and progesterone pathway genes in preeclampsia patients and controls in Bavaria

  2020cites this paper
• The Genetic Background of Endometriosis: Can ESR2 and CYP19A1 Genes Be a Potential Risk Factor for Its Development?

  2020cites this paper
• Personalized functional gynecology: a new direction?

  2020cites this paper
• Baseline estrogen levels in postmenopausal women participating in the MAP.3 breast cancer chemoprevention trial.

  2020cites this paper
• CYP19A1 rs10046 pharmacogenetics in postmenopausal breast cancer patients treated with aromatase inhibitors: One-year follow-up.

  2020cites this paper
• Aromatase (CYP19A1) gene variants, sex steroid levels, and late‐life depression

  2019cites this paper
• A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First‐Line Exemestane: Results From a Prospective Study

  2019cites this paper
• Sequence variants in FSHR and CYP19A1 genes and the ovarian response to controlled ovarian stimulation.

  2019cites this paper
• Genetic Polymorphism in Sex Hormone-binding Globulin With a Prognosis of Androgen Deprivation Therapy in Metastatic Prostate Cancer Among Japanese Men.

  2019cites this paper
• Mutation Frequency in BRCA1 And BRCA2 Genes Among Women with Breast Cancer in Kabardino-Balkaria

  2019cites this paper
• Breast cancer susceptibility genes in estrogen metabolizing pathway in a southern Indian population

  2019cites this paper
• Green Tea Catechin Extract Supplementation Does Not Influence Circulating Sex Hormones and Insulin-Like Growth Factor Axis Proteins in a Randomized Controlled Trial of Postmenopausal Women at High Risk of Breast Cancer.

  2019cites this paper
• Genetic polymorphisms of the SHBG gene can be the effect on SHBG and HDL-cholesterol levels in Coronary Heart Disease: a case–control study

  2019cites this paper
• Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer

  2019cites this paper
• Role of hydroxysteroid (17beta) dehydrogenase type 1 in reproductive tissues and hormone-dependent diseases.

  2019cites this paper
• Common genetic variants in the sex hormone-binding globulin (SHBG) gene in idiopathic recurrent pregnancy loss: a case control study

  2018cites this paper
• Elevated Aromatase (CYP19A1) Expression Is Associated with a Poor Survival of Patients with Estrogen Receptor Positive Breast Cancer

  2018cites this paper
• Four CYP19A1 Polymorphisms and Breast Cancer Risk: A Meta-Analysis

  2018cites this paper
• Genetic variants in sex hormone pathways and the risk of type 2 diabetes among African American, Hispanic American, and European American postmenopausal women in the US

  2018cites this paper
• Nghiên cứu mối liên quan giữa một số đa hình đơn nucleotide ở gen CYP19A1 và

  2018cites this paper
• Germline genetic predictors of aromatase inhibitor concentrations, estrogen suppression and drug efficacy and toxicity in breast cancer patients.

  2017cites this paper
• An independent validation study of three single nucleotide polymorphisms at the sex hormone-binding globulin locus for testosterone levels identified by genome-wide association studies

  2017cites this paper
• Genetic Polymorphisms in Aromatase (CYP19) Gene and Cancer

  2017cites this paper
• Modulation of SHBG binding to testosterone and estradiol by sex and morbid obesity.

  2017cites this paper
• Explorer Functional Genetic Polymorphisms in the Aromatase Gene CYP 19 Vary the Response of Breast Cancer Patients to Neoadjuvant Therapy with Aromatase Inhibitors

  2017cites this paper
• CYP19A1 polymorphisms associated with coronary artery disease and circulating sex hormone levels in a Chinese population

  2017cites this paper
• Polymorphism in xenobiotic and estrogen metabolizing genes, exposure to perfluorinated compounds and subsequent breast cancer risk: A nested case‐control study in the Danish National Birth Cohort

  2017influential citation
• Pharmacogenetics and aromatase inhibitor induced side effects in breast cancer patients.

  2017cites this paper
• Investigation of polymorphisms in genes involved in estrogen metabolism in menstrual migraine.

  2017cites this paper
• trans-Germline genetic predictors of aromatase inhibitor concentrations, estrogen suppression and drug efficacy and toxicity in breast cancer patients

  2017cites this paper
• Association between the Asp 327 Asn Polymorphism of Sex Hormone-Binding Globulin Gene and Prostate Cancer

  2017cites this paper
• The Association of CYP19A1 Variation with Circulating Estradiol and Aromatase Inhibitor Outcome: Can CYP19A1 Variants Be Used to Predict Treatment Efficacy?

  2017cites this paper
• Rs1008805 polymorphism of CYP19A1 gene is associated with the efficacy of hormone therapy in stage I-II and operable stage III breast cancer.

  2017cites this paper
• SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway

  2017cites this paper
• A Reappraisal of Testosterone's Binding in Circulation: Physiological and Clinical Implications.

  2017cites this paper
• Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial

  2016cites this paper
• The neurobiological basis of human aggression: A review on genetic and epigenetic mechanisms

  2016cites this paper
• CYP19A1 Genetic Polymorphisms rs4646 and Osteoporosis in Patients Treated with Aromatase Inhibitor-Based Adjuvant Therapy.

  2016cites this paper
• Alcohol-related breast cancer in postmenopausal women – effect of CYP19A1, PPARG and PPARGC1A polymorphisms on female sex-hormone levels and interaction with alcohol consumption and NSAID usage in a nested case-control study and a randomised controlled trial

  2016cites this paper
• Genetic polymorphisms and haplotype of hormone-related genes are associated with the risk of breast cancer in Chinese women.

  2016cites this paper
• Preliminary evidence of altered steroidogenesis in women with Alzheimer's disease: Have the patients "OLDER" adrenal zona reticularis?

  2016cites this paper
• Polymorphisms in CYP19A1 and NFKB1 genes are associated with cutaneous melanoma risk in southern Brazilian patients

  2016cites this paper
• The rs4646 and rs12592697 Polymorphisms in CYP19A1 Are Associated with Disease Progression among Patients with Breast Cancer from Different Racial/Ethnic Backgrounds

  2016influential citation
• Mecanismos moleculares que regulan la expresión de la shbg: implicaciones en la obesidad

  2016cites this paper
• Functional and structural characterization of deleterious nsSNPs of cyp19a1 based on binding affinity and stability - A computational approach

  2016cites this paper
• S4646 polymorphism in CYP19A1 gene is associated with the efficacy of hormone therapy in early breast cancer.

  2015cites this paper
• Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study.

  2015cites this paper
• The BMC Medicine breast cancer collection: an illustration of contemporary research and clinical care

  2015cites this paper
• Gene-gene and gene-environment interactions in prostate, breast and colorectal cancer

  2015cites this paper
• The Analysis of Hormone Replacement Therapy Influence on Il-6 Expression and Mandible T-Score of Postmenopausal Women

  2015cites this paper
• association between the cOMT Val158Met polymorphism and risk of cancer: evidence from 99 case–control studies

  2015cites this paper
• Resistance to Aromatase Inhibitors in Breast Cancer

  2015cites this paper
• Prediction of Response to Aromatase Inhibitors in Breast Cancer

  2015cites this paper
• Polymorphisms in CYP19A1, HSD17B1 and HSD17B2 genes and serum sex hormone level among postmenopausal Japanese women.

  2015cites this paper
• Placental Aromatase Is Deficient in Placental Ischemia and Preeclampsia

  2015cites this paper
• Role of cytochrome P450 genes in breast cancer etiology and treatment: effects on estrogen biosynthesis, metabolism, and response to endocrine therapy

  2015cites this paper
• No associations between aromatase gene polymorphisms and breast cancer risk in Saudi patients

  2015cites this paper
• CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer

  2015influential citation
• Genetic Variant in the CYP19A1 Gene Associated with Coronary Artery Disease

  2015cites this paper
• CYP19A1 Genetic Polymorphisms rs4646 and Osteoporosis in Patients Treated with Aromatase Inhibitor-Based Adjuvant Therapy Aromataz İnhibitörü Bazli Adjuvan Terapi ile Tedavi Edilen Hastalarda CYP19A1 Genetik Polimorfizmi rs4646 ve Osteoporoz

  2015cites this paper
• Estrogen-related Polymorphisms in Estonian Patients with Age-related Cataract

  2015cites this paper
• The CYP19 RS4646 Polymorphism IS Related to the Prognosis of Stage I–II and Operable Stage III Breast Cancer

  2015cites this paper
• SHBG Gene Polymorphism (rs1799941) Associates with Metabolic Syndrome in Children and Adolescents

  2015cites this paper
• Evidence of androgen action in endometrial and ovarian cancers.

  2014cites this paper
• CYP2C19 polymorphism increases the risk of endometriosis

  2014cites this paper
• Obesity Related Adipokine Resistin Molecular Actions and Clinical Significance in Breast Cancer

  2014cites this paper
• ASSOCIATIONS BETWEEN POLYMORPHISMS AND ABNORMAL RPFNA CYTOMORPHOLOGY IN HIGH-RISK POSTMENOPAUSAL WOMEN TAKING HRT

  2014cites this paper
• Germline variants in the CYP19A1 gene are related to specific adverse events in aromatase inhibitor users: a substudy of Dutch patients in the TEAM trial

  2014cites this paper
• Association of Genetic Polymorphisms in HSD17B1, HSD17B2 and SHBG Genes with Hepatocellular Carcinoma Risk

  2014cites this paper
• Associations between CYP19A1 polymorphisms, Native American ancestry, and breast cancer risk and mortality: the Breast Cancer Health Disparities Study

  2014cites this paper
• Interpreting plasma estrogen levels in breast cancer: caution needed.

  2014cites this paper
• Genome-wide association studies on serum sex steroid levels.

  2014cites this paper
• Association of the (TAAAA)n repeat polymorphism of SHBG gene with the age at menopause in Greek postmenopausal women.

  2014cites this paper
• Polymorphisms in Phase I and Phase II genes and breast cancer risk and relations to persistent organic pollutant exposure: a case–control study in Inuit women

  2014cites this paper
• Genetically predicted 17β-estradiol and systemic inflammation in women: a separate-sample Mendelian randomisation analysis in the Guangzhou Biobank Cohort Study

  2014cites this paper
• Association between the CYP1A2 polymorphisms and risk of cancer: a meta-analysis

  2014cites this paper